RecallRadar

FDA Drug recall D-0337-2025

Lacosamide Tablets, 50mg, 60-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, I…

On 2025-04-16 the FDA classified a Class II recall of Lacosamide Tablets, 50mg, 60-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, I… by Glenmark Pharmaceuticals Usa, citing CGMP Deviations.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0337-2025
ClassificationClass II
Statusongoing
Initiated2025-03-13
Published2025-04-16
Last updated2026-09-13 11:52 UTC
CompanyGlenmark Pharmaceuticals Usa
DistributionUS

Product

Lacosamide Tablets, 50mg, 60-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-678-60

Reason

CGMP Deviations

Identifiers

ndc68462-678-30
ndc68462-678-60
ndc68462-678-10
ndc68462-679-30
ndc68462-679-60
ndc68462-679-10
ndc68462-680-30
ndc68462-680-60
ndc68462-680-10
ndc68462-681-30
ndc68462-681-60
ndc68462-681-10
code_infoLot # 17240221, exp. date Jan-26 17240222, exp. date Jan-26

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0337-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.